New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 6, 2014
09:19 EDTMNK, QCOR, CIReimbursement for Questcor Acthar by Cigna mostly unchanged, says CRT Capital
After Cigna (CI) updated its coverage policy for Questcor's (QCOR) Acthar, CRT Capital thinks the new rules may be viewed as more restrictive than previously. However, the firm thinks that Cigna's reimbursement policies for Actharfor indications other than MS flares are mostly unchanged. It keeps a Fair Value rating on Mallinkrodt, which has agreed to buy Questcor.
News For MNK;QCOR;CI From The Last 14 Days
Check below for free stories on MNK;QCOR;CI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 31, 2014
14:00 EDTCIFBR Capital to hold a conference
Healthcare Conference to be held in Boston on September 3.
August 28, 2014
09:03 EDTMNKMallinckrodt to present data on MNK-155, XARTEMIS XR at PAINWeek
Subscribe for More Information
August 25, 2014
10:40 EDTMNKBiotechs rise after InterMune acquired by Roche
Subscribe for More Information
August 22, 2014
09:02 EDTMNKMallinckrodt names Furey Chief Compliance Officer
Subscribe for More Information
August 21, 2014
16:09 EDTCICigna expects to reaffirm FY14 income guidance of $1.94B-$2.0B
Subscribe for More Information
15:16 EDTMNKDEA restricts painkiller drug prescriptions to curb abuse, WSJ reports
The Drug Enforcement Agency, or DEA, will reclassify hydrocodone combination painkiller drugs and place them in the category of medical substances that have the highest potential for harm in an attempt to curb the widespread abuse of the drugs, according to The Wall Street Journal. The rescheduling of the drugs will take effect in 45 days and result in people being able to obtain the drug for only 90 days without obtaining a new prescription. Major manufacturers of these drugs include Teva Pharmaceutical (TEVA), Mallinckrodt (MNK), AbbVie (ABBV), and Actavis (ACT). Reference Link
August 19, 2014
09:21 EDTMNKMallinckrodt now a component of the S&P 500 Index
The inclusion comes following the completion of Mallinckrodt’s acquisition of Questcor Pharmaceuticals last week. In addition to increasing the market capitalization of Mallinckrodt, the combination has significantly strengthened the company’s balance sheet, cash generation and leverage position.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use